|
|
29-Jan-2007
BioProgress plc ('BioProgress') (AIM: BPRG; NASDAQ: BPRG), the specialty pharma and healthcare company and Magenta Oral Dose Design a business unit of FMC Corporation (‘FMC’) (NSYE: FMC) are pleased to confirm the finalisation of the restructuring agreements regarding the licensing of NRobe technology.
For more information please click here
|
|
|
|
|